期刊文献+

东莨菪素大鼠在体胃、小肠吸收动力学研究 被引量:8

Studies on absorption kinetics of scopoletin in rat stomachs and intestines
下载PDF
导出
摘要 目的:研究东莨菪素在大鼠胃、小肠的吸收特性。方法:采用大鼠在体胃、小肠吸收实验模型,以高效液相色谱法测定灌注液中药物的浓度,紫外分光光度法测定酚红的浓度。结果:东莨菪素在大鼠胃中2 h的吸收百分率为76.31%;东莨菪素在结肠、十二指肠、回肠、空肠的吸收率分别为46.25%,40.54%,38.21%,32.77%;不同质量浓度东莨菪素(10.014 4,20.028 8,40.057 6 mg.L-1在小肠的吸收速率常数分别为0.643 4,0.613 7,0.597 0h-1;不同pH(6.0,6.8,7.4)在小肠的吸收速率常数分别为0.621 7,0.603 3,0.613 7 h-1。结论:不同质量浓度、pH对东莨菪素在大鼠全肠道的吸收没有显著性影响,药物的吸收呈一级动力学过程,吸收机制主要为被动扩散;东莨菪素在胃肠道均有较好的吸收,结肠为最佳吸收部位,提示适宜制成缓控释制剂。 Objective: To study absorption kinetics of scopoletin in rat stomachs and intestines. Method: Rats was cannulated for in situ recirculation. UV and HPLC methods were used to determine the concentrations of phenolsulfonphthalein and scopoletin, respectively. Result: The absorption rates in rat stomachs at 2 h after administration was 76. 31% ; The absorption rates at colon, duodenum, ileum and jejunum were 46. 25%, 40. 54%, 38.21%, 32.77%, respectively. The absorption rate constant (Ka) at concentrations of 10. 014 4, 20. 028 8-40. 057 6 mg · L^-1 in intestine were 0. 643 4, 0. 613 7, 0. 597 0 h^-1 , respectively. The Ka of seopoletin at pH of 6. 0, 6. 8 and 7.4 in intestine were 0.621 7,0. 603 3,0.613 7 h ^- 1, respectively. Conclusion: The concentrations and pH values of scopoletin solution had no distinctive effect on the absorption kinetics. The absorption of scopoletin was a first-order process with passive diffusion mechanism. Scopoletin was well absorbed at stomachs and intestines in rats. Colon was the best absorption site of scopoletin, which suggest that a sustained-release preparation should be suitable for this compound.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第15期1890-1894,共5页 China Journal of Chinese Materia Medica
基金 分子医学生物技术江苏省重点实验室开放基金项目(164070304301) 江苏省“青蓝工程”学术带头人项目
关键词 东莨菪素 在体胃肠吸收 高效液相色谱法 scopoletin in situ absorption from stomach and intestine HPLC
  • 相关文献

参考文献7

  • 1Liu X L, Zhang L, Fu X L, et al. Effect of scopoletin on PC3 cell proliferation and apoptosis [ J ]. Acta Pharmacol Sin, 2001,22 (10) :928.
  • 2Farah M H, Samuelsson G, Pharmacologically active phenylpropanoids from Senra incana [ J ]. Planta Med, 1992,58 ( 1 ) : 14.
  • 3Kang T H, Pae H O, Jeong S J, et al. Scopoletin: an inducibal nitric oxide synthesis inhibitory active constituent from Artemisia feddei[J]. Planta Med, 1999,65:400.
  • 4Ding Z Q, Dai Yue, Wang Z T. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity [ J ]. Planta Med, 2005,71(2) :183.
  • 5Stewart B H, Chan O H, Jezyk N, et al. Descrimination between drug candidates using models for evaluation of intestinal absorption [ J ]. Adv Drug Deliv Rev, 1997,23 (1) :27.
  • 6毛凤斐 屠锡德 等.黄芩甙大鼠小肠吸收的研究[J].南京药学院学报,1984,15(1):61-61.
  • 7Edwards C. Physiology of the colorectal barrier[ J ]. Adv Drug Deliv Rev, 1997,23(2) :173.

共引文献4

同被引文献105

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部